济民可信
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs 2023-12-26 17:26
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader 2022-08-18 15:25
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002 2022-01-04 10:00
Jemincare Announces the Exclusive License of the Kras Inhibitor to HUYABIO 2021-11-30 20:42
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002 2021-09-14 11:43
1